Learn More
Invitrogen™ SPG20 Polyclonal Antibody

Description
Immunogen sequence: MEQEPQNGEP AEIKIIREAY KKAFLFVNKG LNTDELGQKE EAKNYYKQGI GHLLRGISIS SKESEHTGPG WESARQMQQK MKETLQNVRT RLEILEKGLA TSLQNDLQEV PKLYPEFPPK DMCEKLPEPQ SFSSAPQHAE VNGNTSTPSA GAVAAPASLS LPSQSCPAEA PPAYTPQAAE GHYTVSYGTD SGEFSSVGEE FYRNHSQPPP LETLGLDADE LILIPNGVQI FFVNPAGEVS APSYPGYLRI VRFLDNSLDT VLNRPPGFLQ VCDWLYPLVP DRSPVLKCTA GAYMFPDTML QAAGCFVGVV LSSELPEDDR ELFEDLLRQM SDLRLQANWN RAEEENEFQI.
Specifications
Specifications
| Antigen | SPG20 |
| Applications | ELISA, Western Blot |
| Classification | Polyclonal |
| Concentration | 0.74 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 50% glycerol and 0.01% thimerosal; pH 7.3 |
| Gene | SPART |
| Gene Accession No. | Q8N0X7, Q8R1X6 |
| Gene Alias | AI840044; C79168; KIAA0610; mKIAA0610; Spart; Spartin; Spartin-like protein; spastic paraplegia 20 (Troyer syndrome); spastic paraplegia 20 (Troyer syndrome) homolog; Spastic paraplegia 20 protein; spastic paraplegia 20, spartin (Troyer syndrome) homolog; spastic paraplegia 20, spartin (Troyer syndrome) homolog (human); SPG20; TAHCCP1; Trans-activated by hepatitis C virus core protein 1 |
| Gene Symbols | SPART, Spg20 |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.